These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 17911458)

  • 1. Role of mycophenolate mofetil in the treatment of lupus nephritis.
    Grcevska L; Popovska MM; Dzikova S; Ristovska V; Polenakovic M
    Ann N Y Acad Sci; 2007 Sep; 1110():433-8. PubMed ID: 17911458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil for remission induction in severe lupus nephritis.
    Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D;
    Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
    Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM; Tse KC; Tang CS; Mok MY; Li FK;
    J Am Soc Nephrol; 2005 Apr; 16(4):1076-84. PubMed ID: 15728784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
    Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycophenolate mofetil in the treatment of lupus nephritis, in patients with failure, intolerance or relapses after treatment with steroids and cyclophosphamide].
    Suría S; Checa MD
    Nefrologia; 2007; 27(4):459-65. PubMed ID: 17944583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycophenolate mofetil in lupus nephritis].
    Alvarez L; Rivera F; Gil CM; Jiménez del Cerro LA; Olivares J
    Nefrologia; 2002; 22(1):24-32. PubMed ID: 11987681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis].
    Kise T; Yoshimura H
    Nihon Jinzo Gakkai Shi; 2012; 54(2):86-93. PubMed ID: 22590961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of lupus nephritis with mycophenolate mofetil].
    Celić D; Ilić T; Durdević-Mirković T; Mitić I; Milić B; Curić S
    Med Pregl; 2007; 60 Suppl 2():124-7. PubMed ID: 18928177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in the treatment of glomerular diseases.
    Grcevska L; Polenakovic M
    Prilozi; 2007 Jul; 28(1):57-68. PubMed ID: 17921918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.
    Hu W; Liu Z; Chen H; Tang Z; Wang Q; Shen K; Li L
    Chin Med J (Engl); 2002 May; 115(5):705-9. PubMed ID: 12133539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
    Fu YF; Liu GL
    Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
    Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rescue therapy in lupus nephritis patients with mycophenolate mofetil].
    Pretini VB; Avila López GE; Sesín AM; Dotto BH; Sanchez Freytes M; Sesín J; Vergottini JC
    Rev Fac Cien Med Univ Nac Cordoba; 2006; 63(3):39-46. PubMed ID: 17639816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J; Hu W; Xie H; Zhang H; Chen H; Zeng C; Liu Z; Li L
    Lupus; 2007; 16(9):707-12. PubMed ID: 17728363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M; Jancova E; Rysava R; Merta M; Tesar V
    Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.